Company intelligence / Profile preview
Osel Inc.
Mountain View, California, United Statesoselinc.com ↗
- Ownership
- Private
- Employees
- ~8
- Development stage
- Other
01
Overview
Osel has demonstrated that its lead LBP candidate, CBM588, can improve objective response rate and progression-free survival when combined with immunotherapy in metastatic renal cell carcinoma patients. The company’s pipeline also includes women’s health indications at various stages of development. Clinical data support the potential of LBPs to modulate the human microbiome for therapeutic benefit across multiple disease areas.[8]
- Therapeutic areas
- Women's HealthOncologyInfectious Diseases
- Modalities
- Live Biotherapeutic Products (LBPs), specifically live bacterial therapeutics[1][2][3].
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
City of Hope Comprehensive Cancer Center (for oncology trials)[1][8].Miyarisan Pharmaceutical Co., Ltd. provides the proprietary CBM588 strain used by Osel under license or partnership arrangements for US/EU development.[8]
Beyond the preview
Go deeper on Osel Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Osel Inc..